ArticleMicrobial genomics2021
Distribution and genomic characterization of tigecycline-resistant
Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Community gut colonization byFrontiers in cellular and infection microbiology · 2025Article
- Development and evaluation of rapid and accurate one-tube RPA-CRISPR-Cas12b-based detection of mcr-1 and tet(X4).Applied microbiology and biotechnology · 2024Article
- Dissemination of Ceftriaxone-ResistantAntibiotics (Basel, Switzerland) · 2024Article
- A promising metabolite, 9-aminominocycline, restores the sensitivity of tigecycline againstFrontiers in microbiology · 2024Article
- The ISFrontiers in cellular and infection microbiology · 2024Article
- Distribution and spread of tigecycline resistance geneFrontiers in cellular and infection microbiology · 2024Article
- Molecular mechanisms of tigecycline-resistance amongFrontiers in cellular and infection microbiology · 2024Review
- Detection of tetracycline resistance genes and their diversity inVeterinary world · 2023Article
- The Role of Mobile Genetic Elements in Virulence Factor Carriage from Symptomatic and Asymptomatic Cases of Escherichia coli Bacteriuria.Microbiology spectrum · 2023Article
- Characteristics ofAntibiotics (Basel, Switzerland) · 2023Article
- Low prevalence of mobilized resistance genesFrontiers in microbiology · 2023Article
- Characterization of two multidrug-resistantFrontiers in microbiology · 2023Article
- Article
- Comparison of Fitness Cost, Stability, and Conjugation Frequencies ofAntibiotics (Basel, Switzerland) · 2022Article
- Widespread Dissemination of Plasmid-Mediated Tigecycline Resistance GeneMicrobiology spectrum · 2022Article
- International Spread of Tet(X4)-ProducingFoods (Basel, Switzerland) · 2022Article
- Dissemination and prevalence of plasmid-mediated high-level tigecycline resistance geneFrontiers in microbiology · 2022Review
- Tigecycline-resistantFrontiers in microbiology · 2022Article
- Mobile Tigecycline Resistance: An Emerging Health Catastrophe Requiring Urgent One Health Global Intervention.Frontiers in microbiology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.